USANA (USNA) Q1 2026 earnings review

Top-Line Rebound Masking Severe Profitability Shifts

USANA's strategic pivot to an omnichannel model generated a strong 11% sequential revenue rebound in Q1, breaking a trend of sequential declines. However, the quality of this revenue has structurally degraded. Rise Wellness delivered explosive 741% YoY growth by entering Costco, but its 7.1% gross margin is acting as a massive anchor on consolidated profitability. Meanwhile, previously high-flying Hiya saw active subscribers decline 17% YoY. Management maintains full-year growth guidance, but with an expected 55-60% effective tax rate and margin dilution from new ventures, the bottom-line recovery will severely lag top-line stabilization.

๐Ÿ‚ Bull Case

Core Direct Selling Stabilization

After persistent YoY declines, Core Nutritional Active Customers grew 4% sequentially to 404,000, aided by strong Chinese New Year promotional activity and signs that the new Brand Partner compensation plan is gaining traction.

Explosive Omnichannel Scaling

Rise Wellness achieved triple-digit sequential growth (+143%) as 'Protein Pop' launched nationwide in Costco. This proves management's ability to diversify revenue beyond legacy direct selling.

๐Ÿป Bear Case

Structural Margin Degradation

The very segments driving growth are destroying margin. Rise Wellness operates at a 7.1% gross margin, dragging consolidated gross margin down 280 bps YoY to 76.2%. The high-margin direct selling business is essentially flat.

Punishing Tax Headwinds

Geographic misalignment of revenues and costs is creating a brutally inefficient tax structure. A guided 55-60% effective tax rate for FY26 will consume the majority of operating profits.

โš–๏ธ Verdict: ๐Ÿ”ด

Bearish. While management's diversification strategy is generating raw sales volume, the economics of selling low-margin snacks at Costco fundamentally dilutes the premium financial profile of a legacy direct-selling nutrition business.

Key Themes

CONCERNNEW๐Ÿ”ด๐Ÿ”ด

Rise Wellness Margin Collapse Contradicts Growth Narrative

Management boasts that omnichannel brands are the company's growth engine for FY26, but the data reveals a painful trade-off. Rise Wellness generated an impressive $14M in Q1, but it did so with a 7.1% gross margin. This directly caused a 370 basis point unfavorable impact on consolidated gross margins. Scaling retail distribution requires heavy front-loaded investments in trade support and inventory, meaning this segment will remain a profitability anchor for the foreseeable future.

CONCERNNEW๐Ÿ”ด

Hiya Reversing from Growth Driver to Laggard

Hiya Health, previously acquired to accelerate Direct-to-Consumer (DTC) growth, reported a surprising 17% YoY drop in Active Monthly Subscribers (224k to 186k) and a 13% YoY revenue decline. Management cited Meta advertising algorithm disruptions driving up customer acquisition costs. While sequential numbers ticked up slightly (+2%), the YoY reversing trend is a major red flag for a segment counted on for FY26 growth.

CONCERN๐Ÿ”ด

Geographic Tax Inefficiency

USANA's effective tax rate is crushing its bottom line. Following a massive 72.4% rate in FY25, guidance projects a 55% to 60% rate for FY26. Management attributes this to geographic misalignment between where revenue is generated (heavily Asia-Pacific) and where expenses are incurred (U.S. corporate structure). Until this is structurally resolved, EPS leverage is severely capped.

DRIVERNEW๐ŸŸข

Costco and Target Propelling Rise Wellness

The successful rollout of 'Protein Pop' into Costco locations nationwide drove Rise Wellness to $14M in Q1 sales, up 741% YoY. Furthermore, Hiya is launching in Target stores in April, marking its first move into physical retail. This proves the company's capability in product innovation and retail execution, diversifying away from single-channel direct sales.

DRIVERโšช

In-House Manufacturing Transition

USANA is leveraging its existing infrastructure to begin manufacturing Hiya products in-house. Management expects this to capture significant supply chain savings and gross margin improvements in the second half of FY26, helping offset some of the structural margin degradation from retail channels.

THEMEโšช

Macro Cautions and Tariff Uncertainties

Management continues to express a cautious tone regarding global consumer sentiment and the potential for new U.S./China trade tariffs. The company purposefully maintained elevated inventory levels ($99M) to front-run potential tariff implementations on raw materials.

THEMENEWโšช

Technology Modernization Pivot

Management signaled a shift in IT strategy from slow, in-house development toward adopting best-in-class third-party platforms and AI. The goal is to rapidly modernize the customer experience and drive operating efficiencies. However, the incremental investment for this acceleration is not fully baked into the FY26 outlook, presenting a potential unbudgeted headwind.

Other KPIs

Core Nutritional Segment Revenue (26Q1)$204 million

Stable. While down 3% YoY, it grew 7% sequentially. Active customers also grew 4% QoQ to 404,000, signaling that aggressive Chinese New Year promotional efforts and the rollout of the new Brand Partner compensation plan are succeeding in arresting the multi-quarter slide in the legacy business.

Operating Cash Flow and Liquidity (26Q1)$163 million Cash

The balance sheet remains highly resilient. USANA ended the quarter with $163M in cash and equivalents against just $14M of line-of-credit debt. Inventory levels declined 7% sequentially to $99M as Rise Wellness orders shipped out, freeing up working capital.

Total SG&A Expenses (26Q1)$88.2 million (35.3% of sales)

Down 130 basis points YoY as a percentage of sales. This reflects cost realignment initiatives taken in late FY25 (a 10% workforce reduction) beginning to flow through the P&L, providing much-needed operational efficiency to offset gross margin dilution.

Guidance

FY26 Consolidated Net Sales$925 million - $1.0 billion

Accelerating. The midpoint of $962.5M implies roughly 4% YoY growth compared to FY25's $925.2M. Management explicitly stated that the entirety of this growth will be driven by the omnichannel ventures (Rise and Hiya), not the core business.

FY26 Net Earnings$20 million - $27 million

Reversing. Represents a massive implied improvement versus FY25's severely depressed $10.7M, though still a shadow of the $42M printed in FY24. The wide range reflects volatility in the effective tax rate and execution risk at retail.

FY26 Rise Wellness Net Sales$65 million - $80 million

Accelerating violently. Compared to just $16M in FY25, the midpoint ($72.5M) implies over 350% YoY growth. Management expects the segment to operate at roughly breakeven for the full year as it absorbs heavy trade support and channel expansion investments.

FY26 Hiya Net Sales$140 million - $155 million

Stable to Accelerating. The midpoint implies roughly 11% YoY growth vs the $132M recorded in FY25. Achieving this heavily depends on overcoming current Meta algorithm headwinds and successfully launching in physical retail and international markets in the back half.

Key Questions

Rise Wellness Margin Trajectory

With Rise Wellness operating at a 7.1% gross margin during its rapid Costco expansion phase, what is the structural long-term gross margin profile of this business once it scales, and what specific manufacturing or sourcing levers can be pulled to get there?

Hiya Subscriber Acquisition

Hiya's active monthly subscribers fell 17% year-over-year. Have the Meta advertising algorithm disruptions been fully resolved, and what are the customer acquisition cost (CAC) trends heading into Q2?

Tax Rate Normalization

Given the punitive 55-60% effective tax rate guided for FY26 due to geographic cost/revenue misalignment, what specific corporate structuring or operational footprint changes are being evaluated to return the tax rate to historical norms?

Unbudgeted Technology Spend

You noted that incremental investment for accelerating the third-party technology and AI roadmap is not currently factored into the FY26 outlook. What is the potential magnitude of this capital requirement over the next 12-18 months?